Joon Oh Park

Researcher Next ID · RN-005872

Researcher · Medicine

Seoul, South Korea

Not currently recruitingFunding unknown

Research interests

Medicine

Colorectal Cancer Treatments and Studies

Pancreatic and Hepatic Oncology Research

Cholangiocarcinoma and Gallbladder Cancer Studies

Gastric Cancer Management and Outcomes

Lung Cancer Treatments and Mutations

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet · 2023 · https://doi.org/10.1016/s0140-6736(23)00727-4
Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
Nature Medicine · 2018 · https://doi.org/10.1038/s41591-018-0101-z
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
The Lancet · 2015 · https://doi.org/10.1016/s0140-6736(15)00986-1
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
Science · 2007 · https://doi.org/10.1126/science.1141478

No projects listed.